APA (7th ed.) Citation

SC, G., A, V., IM, J., EJ, L., Z, Y., MG, S., . . . DB, C. (2026). Seladelpar in patients with primary biliary cholangitis and compensated cirrhosis: Efficacy and safety from RESPONSE and ASSURE studies. Hepatology communications, 10(5), . https://doi.org/10.1097/HC9.0000000000000918

Chicago Style (17th ed.) Citation

SC, Gordon, et al. "Seladelpar in Patients with Primary Biliary Cholangitis and Compensated Cirrhosis: Efficacy and Safety from RESPONSE and ASSURE Studies." Hepatology Communications 10, no. 5 (2026). https://doi.org/10.1097/HC9.0000000000000918.

MLA (9th ed.) Citation

SC, Gordon, et al. "Seladelpar in Patients with Primary Biliary Cholangitis and Compensated Cirrhosis: Efficacy and Safety from RESPONSE and ASSURE Studies." Hepatology Communications, vol. 10, no. 5, 2026, https://doi.org/10.1097/HC9.0000000000000918.